An Act Requiring The Use Of Vein Assist Technology Or Phlebotomy Assistance Tools For Patients With Complex Venous Access.
Summary
SB 471 would amend Connecticut’s general statutes to require certain blood-draw and laboratory facilities to use vein assist technology or other phlebotomy assistance tools when treating patients with complex venous access. The affected facilities include clinical laboratories, blood collection facilities, source plasma donation centers, and hospital-affiliated laboratories. The bill is aimed at making blood collection easier and more successful for patients whose veins are difficult to access.
The stated purpose is to improve the quality of care during blood collection and to promote more equitable access to necessary health care services. In practice, the bill would create a new operational requirement for covered facilities to have and use assistive technology or tools for qualifying patients, likely affecting clinical procedures, staff training, and equipment procurement. It would also likely benefit patients who have chronic conditions, disabilities, or other circumstances that make venipuncture difficult.
Impact
The bill would change state law by imposing a new mandate on specified laboratory and blood-collection settings to use vein assist technology or phlebotomy assistance tools for patients with complex venous access. This would affect clinical laboratories, blood donation and plasma centers, and hospital-affiliated labs, potentially requiring them to adopt new equipment, protocols, and training standards. The bill does not specify penalties or implementation details in the text provided, but it would create a statutory obligation for covered entities to accommodate patients with difficult venous access.
Sentiment
No committee transcript or vote record is provided, so there is no documented debate or recorded sentiment to assess. Based on the bill’s stated purpose, the measure appears to be framed as a patient-care and access improvement bill rather than a controversial policy change. The available context suggests a generally supportive, health-equity-oriented intent.
Contention
No specific points of contention are documented in the provided materials. Potential areas of concern, if raised in committee, could include the cost of acquiring vein assist technology, the burden on smaller laboratories or donation centers, and how broadly “complex venous access” would be defined in practice. However, no speaker or voting record is available here to attribute such concerns to any particular stakeholder.